Literature DB >> 16302801

Pharmacophoric features of biguanide derivatives: an electronic and structural analysis.

Prasad V Bharatam1, Dhilon S Patel, Pansy Iqbal.   

Abstract

The structure and electronic structure of drugs determine their mechanism of action. Correct structural representation of drugs helps in the proper identification of pharmacophoric features. Biguanide derivatives are a very important class of drugs, but their electronic structure was not clearly understood. Ab initio MO and density functional studies revealed the structure of the most stable tautomer of biguanide. (i) Electron delocalization, (ii) 1,3-H shift, (iii) 1,5-H shift, (iv) protonation, and (v) deprotonation processes, etc., have been investigated for biguanide. The molecular electrostatic potential (MESP) surfaces of neutral, protonated, and deprotonated biguanide have been shown to be similar in their most stable arrangements. The electrostatic potential of the complementary surface where these systems may bind also could be identified. Finally, the most stable structure of the important biguanide derivatives has been given after performing a conformational search.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302801     DOI: 10.1021/jm050602z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Pharmacophoric features of drugs with guanylurea moiety: an electronic structure analysis.

Authors:  Yoganjaneyulu Kasetti; Prasad V Bharatam
Journal:  J Mol Model       Date:  2013-01-17       Impact factor: 1.810

2.  Computer-aided molecular design of 1H-imidazole-2,4-diamine derivatives as potential inhibitors of Plasmodium falciparum DHFR enzyme.

Authors:  Legesse Adane; Prasad V Bharatam
Journal:  J Mol Model       Date:  2010-06-05       Impact factor: 1.810

3.  Responsiveness of parasite Cys His proteases to iron redox.

Authors:  Thomas D Lockwood
Journal:  Parasitol Res       Date:  2006-07-06       Impact factor: 2.289

4.  Quantum chemical study in exploring the role of donor→acceptor interactions in 1,3-bis carbene-stabilized guanidinium cations.

Authors:  Pravin J Wanjari; Tejender Singh; Firdoos Ahmad Sofi; Prasad V Bharatam
Journal:  J Mol Model       Date:  2021-02-17       Impact factor: 1.810

Review 5.  Biguanide is a modifiable pharmacophore for recruitment of endogenous Zn2+ to inhibit cysteinyl cathepsins: review and implications.

Authors:  Thomas D Lockwood
Journal:  Biometals       Date:  2019-05-01       Impact factor: 2.949

6.  A combination therapy strategy for treating antibiotic resistant biofilm infection using a guanidinium derivative and nanoparticulate Ag(0) derived hybrid gel conjugate.

Authors:  Ananta Dey; Manisha Yadav; Deepak Kumar; Anik Kumar Dey; Sweety Samal; Subhash Tanwar; Debrupa Sarkar; Sumit Kumar Pramanik; Susmita Chaudhuri; Amitava Das
Journal:  Chem Sci       Date:  2022-07-27       Impact factor: 9.969

7.  Synthesis and activity of biomimetic biofilm disruptors.

Authors:  Thomas Böttcher; Ilana Kolodkin-Gal; Roberto Kolter; Richard Losick; Jon Clardy
Journal:  J Am Chem Soc       Date:  2013-02-18       Impact factor: 15.419

8.  Diosgenin from Dioscorea bulbifera: novel hit for treatment of type II diabetes mellitus with inhibitory activity against α-amylase and α-glucosidase.

Authors:  Sougata Ghosh; Piyush More; Abhishek Derle; Ajay B Patil; Pramod Markad; Adersh Asok; Navanath Kumbhar; Mahemud L Shaikh; Boppana Ramanamurthy; Vaishali S Shinde; Dilip D Dhavale; Balu A Chopade
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.